# TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

> **NCT03296813** · PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 2973 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Torsemide
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT03296813
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-11
- **Primary completion:** 2022-07-29
- **Final completion:** 2022-07-29
- **Target enrollment:** 2973 (ACTUAL)
- **Last updated:** 2025-10-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296813, "TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03296813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*